Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Reinhardt

Showing results (181-190 of 223) with videos related to

Pageof 23
Sort By:
Blood|November 4, 2010
High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)Jenny E Kuipers, Eva A Coenen, Brian V Balgobind, et al.
Haematologica|December 8, 2010
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemiaIris H I M Hollink, Marry M van den Heuvel-Eibrink, Susan T C J M Arentsen-Peters, et al.
Annals of Hematology|July 12, 2011
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)Friederike Schneider, Eva Hoster, Stephanie Schneider, et al.
Pediatric Blood & Cancer|September 17, 2021
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 StudyKim Klein, H Berna Beverloo, Martin Zimmermann, et al.
Blood|August 5, 2011
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression patternIris H I M Hollink, Marry M van den Heuvel-Eibrink, Susan T C J M Arentsen-Peters, et al.
Blood|December 9, 2022
RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemiaSofia Gialesaki, Daniela Bräuer-Hartmann, Hasan Issa, et al.
Blood Advances|August 9, 2024
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)Dieter Weichenhan, Anna Riedel, Etienne Sollier, et al.
Pediatric Blood & Cancer|March 10, 2025
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaAndrew E Place, Seth E Karol, Christopher J Forlenza, et al.
Cancers|June 2, 2021
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COGMareike Rasche, Martin Zimmermann, Emma Steidel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid LeukemiaRaj Bhayadia, Kathrin Krowiorz, Nadine Haetscher, et al.
Pageof 23

Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Blood|November 4, 2010
High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23)Jenny E Kuipers, Eva A Coenen, Brian V Balgobind, et al.
Haematologica|December 8, 2010
Characterization of CEBPA mutations and promoter hypermethylation in pediatric acute myeloid leukemiaIris H I M Hollink, Marry M van den Heuvel-Eibrink, Susan T C J M Arentsen-Peters, et al.
Annals of Hematology|July 12, 2011
Age-dependent frequencies of NPM1 mutations and FLT3-ITD in patients with normal karyotype AML (NK-AML)Friederike Schneider, Eva Hoster, Stephanie Schneider, et al.
Pediatric Blood & Cancer|September 17, 2021
Prognostic significance of chromosomal abnormalities at relapse in children with relapsed acute myeloid leukemia: A retrospective cohort study of the Relapsed AML 2001/01 StudyKim Klein, H Berna Beverloo, Martin Zimmermann, et al.
Blood|August 5, 2011
NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression patternIris H I M Hollink, Marry M van den Heuvel-Eibrink, Susan T C J M Arentsen-Peters, et al.
Blood|December 9, 2022
RUNX1 isoform disequilibrium promotes the development of trisomy 21-associated myeloid leukemiaSofia Gialesaki, Daniela Bräuer-Hartmann, Hasan Issa, et al.
Blood Advances|August 9, 2024
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)Dieter Weichenhan, Anna Riedel, Etienne Sollier, et al.
Pediatric Blood & Cancer|March 10, 2025
Venetoclax Combined With Chemotherapy in Pediatric and Adolescent/Young Adult Patients With Relapsed/Refractory Acute Lymphoblastic LeukemiaAndrew E Place, Seth E Karol, Christopher J Forlenza, et al.
Cancers|June 2, 2021
Survival Following Relapse in Children with Acute Myeloid Leukemia: A Report from AML-BFM and COGMareike Rasche, Martin Zimmermann, Emma Steidel, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 13, 2018
Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid LeukemiaRaj Bhayadia, Kathrin Krowiorz, Nadine Haetscher, et al.
Pageof 23